Literature DB >> 4058623

Carnitine kinetics during dialysis. Evidence of unilateral transport from tissues to plasma.

G Panzetta, G Bonadonna, P Giovene, D De Grandis.   

Abstract

Plasma total and free carnitine concentrations were measured in 14 patients during a 4-hour hemodialysis session at 40-min intervals. Although postdialysis carnitine levels were lower than predialysis levels, they did not drop progressively and rebound occurred early or late. While no relationship was seen between pre- and postdialysis carnitine values, an inverse correlation was found when the predialysis value was compared with an end-dialysis to predialysis ratio. Our data are not consistent with a first-order elimination kinetics of the molecule and suggest that during dialysis carnitine may be actively released from tissue stores to plasma pool. The finding of an inverse correlation between the fractional change (post-pre ratio) of plasma carnitine and its predialysis level suggests that plasma carnitine supply from cells is more active when plasma carnitine levels are lower.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4058623     DOI: 10.1159/000183588

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  5 in total

1.  Potential role of carnitine in patients with renal insufficiency.

Authors:  C Wanner; W H Hörl
Journal:  Klin Wochenschr       Date:  1986-07-01

2.  Effect of hemodialysis session on the dynamics of carnitine ester profile changes in L-carnitine pretreated end-stage renal disease patients.

Authors:  Botond Csiky; Judit Bene; Istvan Wittmann; Endre Sulyok; Bela Melegh
Journal:  Int Urol Nephrol       Date:  2012-06-10       Impact factor: 2.370

3.  Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome.

Authors:  W A Gahl; I Bernardini; M Dalakas; W B Rizzo; G S Harper; J M Hoeg; O Hurko; J Bernar
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 4.  Pharmacokinetics of L-carnitine.

Authors:  Allan M Evans; Gianfranco Fornasini
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 5.  Capsular fibrosis: a review of prevention methods and management.

Authors:  Andreea D Fișuș; Oliver Findl
Journal:  Eye (Lond)       Date:  2019-12-05       Impact factor: 3.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.